Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow

The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer

(2016) Yusuke Shiozawa et al.   Oncotarget

CCL9 Induced by TGF  Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

(2015) H. H. Yan et al.   CANCER RESEARCH

TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma

(2015) Naoki Oshimori et al.   CELL

Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinoma

(2015) Patrick Reichl et al.   HEPATOLOGY

Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells

(2015) Devon A. Lawson et al.   NATURE

NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmes

(2015) Maria Soledad Sosa et al.   Nature Communications

Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy

(2015) Nazanin Ruppender et al.   PLoS One

Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells

(2015) Takuya Nakamura et al.   Oncotarget

Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways

(2015) Lisly Chéry et al.   Oncotarget

GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche

(2015) Yusuke Shiozawa et al.   NEOPLASIA

Prevalence of Prostate Cancer Metastases after Intravenous Inoculation Provides Clues into the Molecular Basis of Dormancy in the Bone Marrow Microenvironment

(2015) Younghun Jung et al.   NEOPLASIA

Molecular Pathways: Niches in Metastatic Dormancy

(2014) K. Yumoto et al.   CLINICAL CANCER RESEARCH

A novel method for monitoring tumor proliferation in vivo using fluorescent dye DiD

(2014) Kenji Yumoto et al.   CYTOMETRY PART A

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Receptor Tyrosine Kinases, TYRO3, AXL, and MER, Demonstrate Distinct Patterns and Complex Regulation of Ligand-induced Activation

(2014) Wen-I Tsou et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling

(2013) Paloma Bragado et al.   NATURE CELL BIOLOGY

Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer

(2013) S Mishra et al.   ONCOGENE

GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor Formation

(2013) Russell S. Taichman et al.   PLoS One

Biology of the TAM Receptors

(2013) G. Lemke   Cold Spring Harbor Perspectives in Biology

The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites

(2012) Hua Gao et al.   CELL

Disseminated Prostate Cancer Cells Can Instruct Hematopoietic Stem and Progenitor Cells to Regulate Bone Phenotype

(2012) J. Joseph et al.   MOLECULAR CANCER RESEARCH

Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow

(2011) Yusuke Shiozawa et al.   JOURNAL OF CLINICAL INVESTIGATION

Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone

(2011) Aya Kobayashi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999–2006

(2011) N Sathiakumar et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Advances in the biology of bone metastasis: How the skeleton affects tumor behavior

(2010) Julie A. Sterling et al.   BONE

Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma

(2010) Xianzhou Song et al.   CANCER

TAM receptor signaling and autoimmune disease

(2010) Carla V Rothlin et al.   CURRENT OPINION IN IMMUNOLOGY